Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update
✍ Scribed by Xuyu Zu; Qinghai Zhang; Renxian Cao; Jianghua Liu; Jing Zhong; Gebo Wen; Deliang Cao
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 468 KB
- Volume
- 347
- Category
- Article
- ISSN
- 0302-766X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Transforming growth factor‐β (TGF‐β) family members are polypeptides with dual tumor suppressive and oncogenic effects. They signal through serine/threonine kinase receptor complexes, which phosphorylate cytoplasmic mediators, the Smads. Upon phosphorylation, Smads translocate to the nu
Biliary tract carcinoma is a common neoplasm in Japan, and its treatment is difficult because it tends to promote fibrosis and easily invades surrounding tissues. To better characterize the biological features of this carcinoma, we investigated abnormalities in the transforming growth factor- (TGF-
The progression of breast cancer depends on the establishment of a neovasculature, by a process called angiogenesis. Angiogenesis is an invasive cellular event that requires the co-ordination of numerous molecules including growth factors and their receptors, extracellular proteins, adhesion molecul
Cytokines and growth factors are powerful modulators of the immune response. Their aberrant expression either by the tumor cells or by the tumor infiltrating lymphocytes confers a selective advantage to the tumor to grow and suppress the cytotoxic activity of the infiltrating lymphocytes. Therefore,